FGAM
ALXN

Financial Gravity Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Financial Gravity Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-11
Closed -$184K – 1040
2021
Q2 		$184K Sell
11
-6
-35% -$1.03K 0.07% 205
2021
Q1 		$2.52K Sell
17
-49
-74% -$7.58K 0.05% 223
2020
Q4 		$10K Buy
+66
New +$8.48K 0.01% 182
2020
Q2 		– Sell
-429
Closed -$38.5K – 1039
2020
Q1 		$38.5K Sell
429
-292
-40% -$28.7K 0.12% 78
2019
Q4 		$108K Sell
721
-365
-34% -$39K 0.07% 291
2019
Q3 		$106K Sell
1,086
-244
-18% -$27.5K 0.09% 197
2019
Q2 		$174K Sell
1,330
-282
-17% -$36.3K 0.14% 159
2019
Q1 		$218K Buy
+1,612
New +$200K 0.18% 124
2018
Q3 		$215K Buy
1,919
+297
+18% +$37.3K 0.23% 103
2018
Q2 		$193K Sell
1,622
-223
-12% -$26.1K 0.18% 122
2018
Q1 		$211K Buy
+1,845
New +$221K 0.22% 85

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return